Loss of IκB kinase β promotes myofibroblast transformation and senescence through activation of the ROS-TGFβ autocrine loop by unknown
RESEARCH ARTICLE
Loss of IκB kinase β promotes myoﬁbroblast
transformation and senescence through
activation of the ROS-TGFβ autocrine loop
Liang Chen1, Zhimin Peng1, Qinghang Meng1, Maureen Mongan1, Jingcai Wang1, Maureen Sartor1,
Jing Chen1, Liang Niu1, Mario Medvedovic1, Winston Kao2, Ying Xia1,2&
1 Department of Environmental Health and Center of Environmental Genetics, University of Cincinnati Medical Center,
Cincinnati, OH 45267, USA
2 Department of Ophthalmology, University of Cincinnati Medical Center, Cincinnati, OH 45267, USA
& Correspondence: ying.xia@uc.edu (Y. Xia)
Received November 16, 2015 Accepted December 1, 2015
ABSTRACT
Using forward and reverse genetics and global gene
expression analyses, we explored the crosstalk between
the IκB kinase β (IKKβ) and the transforming growth
factor β (TGFβ) signaling pathways. We show that
in vitro ablation of Ikkβ in ﬁbroblasts led to progressive
ROS accumulation and TGFβ activation, and ultimately
accelerated cell migration, ﬁbroblast-myoﬁbroblast
transformation and senescence. Mechanistically, the
basal IKKβ activity was required for anti-oxidant gene
expression and redox homeostasis. Lacking this activ-
ity, IKKβ-null cells showed ROS accumulation and acti-
vation of stress-sensitive transcription factor AP-1/c-
Jun. AP-1/c-Jun activation led to up-regulation of the
Tgfβ2 promoter, which in turn further potentiated intra-
cellular ROS through the induction of NADPH oxidase
(NOX). These data suggest that by blocking the auto-
crine ampliﬁcation of a ROS-TGFβ loop IKKβ plays a
crucial role in the prevention of ﬁbroblast-myoﬁbroblast
transformation and senescence.
KEYWORDS IkB kinase β (IKKβ), nuclear factor κB (NF-
κB), transforming growth factors β (TGFβ), reactive oxygen
species (ROS), myoﬁbroblast, senescence
INTRODUCTION
The IκB kinase β (IKKβ) is a key catalytic subunit of the IKK
complex, involved in inﬂammatory responses. It is robustly
activated by cytokines, bacterial and viral products and
metabolic stresses. IKKβ activation leads to phosphorylation
of inhibitor of κB (IκB), and subsequently, translocation of the
nuclear factor κB (NF-κB) to nucleus. The nuclear NF-κB
binds to the κB elements in gene promoters and enhancers
to either activate or repress gene expression (Perkins,
2007). By regulating genes coding for cytokines, chemoki-
nes, enzymes and molecules with microbicidal activity, the
IKK-NF-κB cascade offers important protection against
stress and danger signals (Vallabhapurapu and Karin, 2009).
Persistent and unrestrained activation of the cascade, on the
other hand, leads to chronic inﬂammation that may be the
underlying cause of detrimental and life-threatening dis-
eases, such as rheumatoid arthritis, atherosclerosis and
cancer (Luo et al., 2005; Kim et al., 2006; Chariot, 2009). For
this reason, inhibition of IKK signaling is widely considered
as a promising strategy for treating many illnesses; the
challenge however is to fully recognize, and develop means
to offset, the potential harmful consequences of pathway
inactivation (Baldwin, Jr., 2001; Li et al., 2002; Bacher and
Schmitz, 2004; Courtois and Gilmore, 2006; Karin, 2006).
IKKβ maintains low static activity in the absence of
external stimuli. This is associated with slow IκB degradation
and equilibrium NF-κB activity (O’Dea et al., 2007). The
basal activity is important for redox homeostasis, thus IKKβ
inactivation renders cells or tissues vulnerable to oxidative
damage (Gerondakis et al., 2006). For example, when Ikkβ
is knocked out in hepatocytes, the livers of the knockout
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mice have normal development, but exhibit elevated levels
of reactive oxygen species (ROS). In addition, IKKβ-defec-
tive livers are susceptible to injuries by carcinogens, con-
canavalin A and bacterial infection (Lavon et al., 2000;
Maeda et al., 2005). When IKKβ is knocked out in ﬁbrob-
lasts, the null cells have elevated ROS levels and are sen-
sitive to damage by stress and injury (Maeda et al., 2005;
Chen et al., 2006; Giorgio et al., 2007; May and Madge,
2007; Sen and Roy, 2010). These observations suggest that
IKKβ may be involved in a plethora of physiological pro-
cesses through the regulation of redox homeostasis (Karin,
2008; Pasparakis, 2009).
In the present work, we investigated the role of IKKβ
through global gene expression analyses and identiﬁed a
crosstalk interaction between IKKβ and TGFβ signaling. We
showed that loss of IKKβ in ﬁbroblasts led to TGFβ activa-
tion, which in turn modulated cell motility, myoﬁbroblast
transformation and senescence. These results suggest that
IKKβ can act as a repressor of the TGFβ pathway.
RESULTS
IKKβ represses TGFβ signaling
To explore the roles of IKK and NF-κB signaling in ﬁbrob-
lasts, we examined global gene expression in wild type and
cells lacking IKKα, IKKβ or the p65 subunit of NF-κB.
Comparison of differentially expressed genes between wild
type and knockout cells, we found that genes up-regulated in
the wild type cells were enriched for the terpenoid backbone
biosynthesis pathway, whereas genes down-regulated in the
wild type cells were enriched for the focal adhesion and
vascular smooth muscle contraction pathways (Table 1).
We further examined differential gene expression
between IKKβ-competent (Ikkβ−/−/Ad-IKKβ) and -deﬁcient
(Ikkβ−/−/Ad-β-Gal and Ikkβ−/−) cells using the same strategy.
Genes up-regulated in the IKKβ-competent cells were, as
expected, enriched for pathways involved in immunity and
inﬂammation, such as antigen processing and presentation,
rheumatoid arthritis, and B cell receptor signaling pathway
and allograft rejection, but intriguingly, genes down-regu-
lated in the IKKβ-competent cells were enriched for focal
adhesion, ECM-receptor interaction and, and the TGFβ
signaling pathways (Table 2).
We validated the array data focusing on IKKβ-repressed
genes of the TGFβ pathway. Compared to the wild type, the
Ikkβ−/− cells had elevated Tgfβ2 and Tgfβ3 mRNA tran-
scripts (Fig. 1A), corresponding to higher gene promoter
activities (Fig. 1B). They also exhibited increased SMAD
transcriptional activity (Fig. 1C) and phosphorylation
(Fig. 1D), as well as increased expression of a number of
SMAD target genes, such as Smad6, Ctgf and Acta2
(Figs. 1E and S1). In addition, we observed the expression
of myoﬁbroblast marker α smooth muscle actin (α-SMA), the
product of Acta2, in IKKβ-null but not wild type cells
(Fig. 1D). Adenoviral-mediated expression of IKKβ, but not
of GFP used as control, in the null cells repressed Tgfβ
expression and promoter activity, decreased SMAD activity
and target gene expression, similar to the effects of Ad-
SMAD7 and reached the levels same as that in the wild type
cells (Fig. 1A–C and 1E). These results indicate that loss of
IKKβ leads to the activation of TGFβ expression and
signaling.
TGFβ upregulation leads to migration
and myoﬁbroblast transformation of IKKβ-null cells
TGFβ plays a pivotal role in cell proliferation, differentiation,
wound healing and extracellular matrix production, and it
induces growth arrest and myoﬁbroblast transformation in
ﬁbroblasts (Datto et al., 1999; Phan, 2002). Chen, et al. have
reported that the IKKβ-deﬁcient cells grow slower, but
migrate faster (Chen et al., 2006). We conﬁrmed these
observations (Fig. 2A and 2B), and furthermore, we showed
that the migration rate of the null cells was signiﬁcantly
reduced by expression of IKKβ and inhibitory SMAD7, and
by treatment with SB505124, a TGFβ receptor inhibitor
(Fig. 2B and 2C).
To assess if promoted migration was due to TGFβ
secretion, we collected conditioned medium from wild type
and Ikkβ−/− cultures and examined its effects on migration of
the wild type cells. The wild type-conditioned medium had no
effect, but the Ikkβ−/−-conditioned medium accelerated
migration by 50% (Fig. 2D). Additionally, the migration
Table 1. Biological pathways affected by the IKK-NF-κB cascade*
WT vs. Ikkα−/− WT vs. Ikkβ−/− WT vs. p65−/−
Up-regulated genes enriched pathways
Terpenoid backbone biosynthesis 0.003663 1.53 × 10−5 0.014653
Down-regulated genes enriched pathways
Focal adhesion 1.78 × 10−8 0.039390 3.14 × 10−10
Vascular smooth muscle contraction 9.00 × 10−7 0.000589 1.66 × 10−5
* Each entry is the False Discovery Rate (FDR) adjusted P-values for the pathway in the corresponding row in the comparison in the
corresponding column. The P-values were calculated by R package CLEAN using the KEGG pathway database.
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stimulatory activity was abolished by TGFβ neutralizing
antibodies, supporting the notion that TGFβ secreted by the
IKKβ-null cells contributed to the stimulation of ﬁbroblast
migration.
Progressive ROS accumulation and TGFβ activation
following IKKβ ablation
Infection of IkkβF/F embryonic ﬁbroblasts with Ad-Cre could
ablate the Ikkβ gene in vitro. Using this approach, we gen-
erated the IkkβF/F/Ad-Cre cells, in which IKKβ expression,
NF-κB activity, and NF-κB target gene expression were
abolished or signiﬁcantly reduced (Figs. 3A and S2A–S2E).
Infection of the IkkβF/F/Ad-Cre cells with Ad-IKKβ, but not
Ad-GFP, restored NF-κB activity and target gene expression
(Fig. S2D and S2E).
The IkkβF/F/Ad-Cre cells lacked IKKβ, but surprisingly,
they did not have detectable α-SMA expression immediately
following Ad-Cre infection (Fig. 3A). These cells instead
displayed a gradual increase in the expression of α-SMA,
TGFβ2 and SMAD-target genes (Fig. 3A and 3B), and they
exhibited faster migration only after 90 days of Ad-Cre
infection (Fig. 3C). Simultaneous ablation of IKKβ and TGFβ
receptor 2 reduced α-SMA upregulation and TGFβ1-induced
migration (Figs. 3D, 3E and S3). The data derived from the
in vitro gene ablation system suggest that IKKβ loss leads to
a gradual activation of TGFβ signaling and progressive
myoﬁbroblast conversion.
Loss of IKKβ leads to activation of the ROS-TGFβ-NOX
cascade
Consistent with the notion that IKKβ represses reactive oxygen
species (ROS) (Tanaka et al., 1999; Maeda et al., 2005), we
showed that the H2O2 level, measured by 2′,7′-Dichlorodihy-
droﬂuorescein diacetate (CM-H2DCFDA) labeling, was high in
Ikkβ−/− but low in wild type cells (Fig. S4A). In addition, the
expression of the oxidative stress-inducible biomarker gene
Heme oxygenase 1 (Ho-1) was more abundant in Ikkβ−/− than
wild type cells (Fig. 4A). The IKKβ- and p65-deﬁcient cells have
similar gene expression signatures and faster migration phe-
notype (Table 1 and Fig. S5), and like the IKKβ-null cells, the
p65−/− cells also had increased Ho-1 expression (Fig. 4B).
Furthermore, we detected in the p65−/− cells decreased
expression of superoxide dismutase 2 (Sod2), encoding for a
crucial redox scavenger. Correspondingly, compared to the
IKKβ-competent, i.e. wild type and Ikkβ−/−/Ad-IKKβ, cells, the
IKKβ-deﬁcient Ikkβ−/−cells had decreased level of RNA pol II
recruitment to the Sod2 promoter and reduced p65 bound at
the gene enhancer (Fig. 4C).
To evaluate if SOD2 reduction contributed to TGFβ acti-
vation, we expressed SOD2 in IKKβ-null cells and observed
Table 2. The IKKβ-regulated biological pathways*
Ad-IKKβ vs. uninfected Ad-IKKβ vs. Ad-β-Gal
Up-regulated genes enriched pathways
Antigen processing and presentation 3.74 × 10−6 4.02 × 10−6
Leishmaniasis 3.69 × 10−5 3.29 × 10−12
Phagosome 4.00 × 10−5 0.002085
Rheumatoid arthritis 1.51 × 10−9
B cell receptor signaling pathway 0.000402 0.000641
Graft-versus-host disease 0.002208 0.002457
Allograft rejection 0.003035 0.004726
Type I diabetes mellitus 0.009985 0.022062
Autoimmune thyroid disease 0.013477 0.025376
Down-regulated genes enriched pathways
Focal adhesion 0.000511 6.21 × 10−6
TGFβ signaling pathway 0.009496 0.028866
ECM-receptor interaction 4.73 × 10−8 4.70 × 10−7
Protein digestion and absorption 1.18 × 10−7 0.001664
Amoebiasis 5.40 × 10−6 0.000540
* Each entry is the False Discovery Rate (FDR) adjusted P-values for the pathway in the corresponding row in the comparison in the
corresponding column. The P-values were calculated by R package CLEAN using the KEGG pathway database.
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a signiﬁcant decrease of Tgfβ2 promoter and SMAD activity
(Fig. 4D). We further showed that SOD2 expression caused
down-regulation of ROS-sensitive AP-1 activity, raising the
possibility that the TGFβ signaling was actually modulated
by cellular redox status (Bataller et al., 2003; Fleckenstein
et al., 2007; Roy et al., 2011). To test the possibility, we
treated the wild type cells with pro-oxidant L-Buthionine
sulphoximine (BSO), and the Ikkβ−/− cells with anti-oxidant
N-acetyl cysteine (NAC). As predicted by the hypothesis,
BSO increased Tgfβ2 gene expression and promoter activity
and NAC signiﬁcantly attenuated them, and reduced SMAD
activity and migration of the IKKβ-deﬁcient cells (Fig. 4E–G).
These data suggest that SOD2 reduction and ROS accu-
mulation contribute to TGFβ activation in the IKKβ-null cells.
TGFβ, on the other hand, has been shown to activate
NADPH oxidases (NOX), which could further augment ROS
(Hecker et al., 2009; Bondi et al., 2010). By monitoring
intracellular glutathione (GSH), the most abundant redox
scavenger, we observed that treating cells with TGFβ1
caused GSH depletion, whereas treating cells with TGFβ
inhibitors restored GSH in IKKβ-null and TGFβ1 treated wild
type cells (Anderson, 1998) (Fig. 5A). Furthermore, the
IKKβ-null cells had high levels of NOX1 and NOX4
expression and NOX inhibitors abolished TGFβ-induced
GSH depletion in these cells (Armstrong et al., 2002; Bedard
and Krause, 2007) (Fig. 5B and 5C).
Taken together, the above data suggest a scenario that
reduction of redox scavengers in IKKβ-null cells could lead
to ROS accumulation; the oxidative stresses in turn might
activate the TGFβ-NOX cascade to further augment ROS.
IKKβ ablation therefore leads to the activation of an auto-
crine cycle of ROS ampliﬁcation. Consistent with the con-
clusion, we found that Ad-Cre infection of the IkkβF/F cells led
to a gradual ROS increase. While 36% IkkβF/F/Ad-Cre cells
displayed high H2O2 level at 30 days of Ad-Cre infection, the
number increased to almost 50% at 90 days after infection
(Fig. S4B and S4C). Similarly, the HO-1 expression
increased gradually after Ad-Cre infection of IkkβF/F cells,
and by 180 days, it reached the levels similar to that in
Ikkβ−/− cells and twice that in wild type or Ad-IKKβ-infected
IkkβF/F/Ad-Cre cells (Fig. 5D).
AP-1 is involved in ROS-induced TGFβ expression
To identify the molecular link between ROS and TGFβ, we













































































































Figure 1. Loss of IKKβ upregulates TGFβ expression and activity. The IKKβ-competent, i.e. wild type and Ikkβ−/−/Ad-IKKβ, and
IKKβ-deﬁcient, i.e. Ikkβ−/− and Ikkβ−/− /Ad-GFP, ﬁbroblasts were examined for Tgfβ2 and 3 (A) mRNA expression and (B) promoter
activity, and for (C) basal (un-treated) and TGFβ1-induced SMAD activity (SBE-luc) and (D) SMAD phosphorylation, and IKKβ, α-
SMA and β-actin expression. (E) The Ikkβ−/− cells, either uninfected or infected with Ad-IKKβ and Ad-SMAD7, were examined for the
expression of SMAD-target genes, i.e. Acta2, Smad6 and Ctgf. Results represent the mean values ± SD from at least three
independent experiments. *P < 0.05, **P < 0.01 and ***P < 0.001 were considered signiﬁcantly different from the wild type or control
samples.
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sites and found two potential AP-1-cJun binding sites
(Fig. S6A). AP-1 is a stress responsive transcription factor;
we tested its activation with a luciferase reporter bearing an
AP-1 binding site and found that luciferase expression was
induced by IKKβ ablation, but repressed by IKKβ expression
and NAC treatment (Fig. 6A). In addition, AP-1 binding to the
Tgfβ2 promoter, as measured by chromatin immunoprecipi-
tation, was increased, associated with the transcriptionally
active H3K4me3 modiﬁcation on the Tgfβ2 promoter, in
IKKβ-deﬁcient cells (Fig. S6B and S6C). Both AP-1 binding
and H3K4me3 were potentiated by IKKβ ablation and BSO
treatment, but reduced by IKKβ over-expression and NAC
treatment (Fig. 6B and 6C).
To validate the role of AP-1-c-Jun, we expressed a domi-
nant negative mutant c-Jun (bdm-c-Jun) in the Ikkβ−/− cells
and found that its expression repressed Tgfβ2 promoter
activity and gene expression (Fig. 6D and 6E). We further
used c-Jun-competent (c-JunF/F/Ad-GFP) and -deﬁcient
(c-JunF/F/Ad-Cre) cells and showed that while c-Jun ablation
did not affect HO-1 induction, it abolished Tgfβ2 induction
under the oxidative stress conditions createdbyBSO treatment
(Fig. 6F). Collectively, our data suggest that the ROS may act
upstream to activate AP-1/c-Jun, which in turn can induce Tgfβ
promoter and gene expression in the Ikkβ-null cells.
Loss of IKKβ leads to senescence
Chronic oxidative stress can induce, stabilize and amplify
senescence, leading ultimately to the detrimental effects of
aging (Passos et al., 2010; Nelson et al., 2012). To assess if
IKKβ ablation could lead to senescence, we examined the
expression of senescence-associated β-Galactosidase (SA-
β-Gal) (Dimri et al., 1995). SA-β-Gal activity was low in IkkβF/F
cells, but gradually increased following Ad-Cre infection; by
180 days after infection the activity reached approximately
50% of the level in Ikkβ−/−cells (Fig. 7A). In Ad-Cre infected
IkkβF/F cells, there was also a progressive increase of the cell
cycle regulator cyclin-dependent kinase inhibitor 1A (p21)
(Cdkn1a), the extracellular matrix component Fibronectin
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Figure 2. IKKβ loss induces TGFβ expression and cell migration. (A) The wild type and Ikkβ−/− ﬁbroblasts were examined for
growth rate. The in vitro wound healing assay was performed on wild type and Ikkβ−/− ﬁbroblasts either uninfected or infected with Ad-
GFP or Ad-IKKβ, or pre-treated with SB505124 for 24 h. (B) The cells were photographed at 0 and 12 h after the scratch wound, and
(C) the speed of healing was calculated. (D) The in vitro wound healing assay was performed on wild type cells in normal growth
medium, condition-medium collected from wild type cells or condition-medium collected from Ikkβ−/− cells with or without anti-pan-
TGFβ. The healing rate was calculated at 12 h after injury. Results represent the mean values ± SD from at least three independent
experiments. **P < 0.01 and ***P < 0.001 were considered signiﬁcantly different from the wild type or control samples.
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DNA double strand damage (Dumont et al., 2000; Debacq-
Chainiaux et al., 2008; Weyemi et al., 2011) (Fig. 7B and 7C).
Furthermore, there was a slight but gradual increase of
telomere shortening, suggesting that IKKβ loss may lead to
irreversible DNA damage and a senescent phenotype (Bala-
ban et al., 2005; Giorgio et al., 2007) (Fig. 7D). Hence, by
repressing the ROS-AP-1-TGFβ axis IKKβ may prevent
senescence in ﬁbroblasts (Fig. 7E).
DISCUSSION
The global gene expression signatures provide an initial clue
that loss of IKKβ or key components of the NF-κB pathways
may lead to activation of TGFβ signaling in ﬁbroblasts. Fol-
lowing this lead, we have identiﬁed a molecular link between
the IKKβ and TGFβ pathways. We show that the IKKβ-NF-
κB cascade sustains the expression of anti-oxidant genes
and that inactivation of this cascade impedes the scavenge
capacity and results in ROS accumulation. Elevated ROS in
turn triggers the feed-forward activation of the ROS-AP-1-
TGFβ-NOX loop that leads ultimately to increased motility,
ﬁbroblast-myoﬁbroblast transformation, and senescence
(Fig. 7E).
The antagonistic relationship between IKK and TGFβ
signaling has been reported in other experimental settings.
For example, in osteoclasts and head and neck cancers,
TGFβ is found acting through the TGFβ activated kinase 1 to
activate IKK and NF-κB, whereas NF-κB up-regulates
SMAD7 to inhibit TGFβ signaling (Gingery et al., 2008;
Freudlsperger et al., 2013). The IKK-NF-κB pathway is also
found to modulate transcription factors/cofactors and atten-
uate SMAD activity (Dennler et al., 2000; Nagarajan et al.,
2000; Bitzer et al., 2000; Verrecchia et al., 2001). Here we
describe a unique mechanism where the crosstalk of IKK
and TGFβ is mediated by ROS. Speciﬁcally, the elevated
ROS in IKKβ-null cells induce c-Jun binding and activation of
the Tgfβ promoter.
There are at least two sources for the ROS in IKKβ-null
cells. First, IKKβ ablation results in insufﬁcient ROS removal
due to down-regulation of antioxidant genes, in agreement
with previous reports (Chen et al., 2003; Sakon et al., 2003;











































































































































Figure 3. IKKβ ablation leads to progressive activation of TGFβ and cell migration. The IkkβF/F ﬁbroblasts were infected with
Ad-GFP or Ad-Cre and the cells were maintained in culture for various days as indicated. The cells were examined for (A) IKKβ, α-
SMA and β-actin protein, (B) mRNA for Tgfβ2 and SMAD-target genes, and (C) rate of wound healing. The IkkβF/F/Tgfbr2F/F
ﬁbroblasts were infected with Ad-GFP or Ad-Cre. At 3 months after infection, the cells were examined for (D) IKKβ, α-SMA and β-actin
protein and (E) rate of in vitro wound healing in the presence or absence of TGFβ1. Results represent the mean values ± SD from at
least three independent experiments. *P < 0.05, **P < 0.01 and ***P < 0.001 were considered signiﬁcantly different from the wild type
or control samples.
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causes increased ROS production as the result of TGFβ
induced NOX4 expression and NADH activity. Interestingly,
the TGFβ-NOX axis itself is also activated by ROS, and thus,
this axis and ROS may form an autocrine loop to amplify
each other. Such feed-forward signal ampliﬁcation is likely to
be responsible for the progressive ROS accumulation and
TGFβ activation in ﬁbroblasts following IKKβ ablation. When
the TGFβ signals reach a threshold level, it is able to induce
cell migration and myoﬁbroblast transformation; when the
chronic ROS reach a threshold level, they may contribute to
premature senescence, as it also happens in cells deﬁcient
in GSH (Chen et al., 2009).
As the IKK-NF-κB cascade is a major player of the
inﬂammatory response, its inhibition is a promising strategy
for treating a vast number of diseases associated with
inﬂammation (McIntyre et al., 2003; Ruocco et al., 2005;
Polzer et al., 2008). In particular, this cascade is considered
a molecular link between inﬂammation and cancer; there-
fore, targeting the cascade has become an attractive ratio-
nale in cancer therapy (Vallabhapurapu and Karin, 2009;
DiDonato et al., 2012). The caveat is that such treatment
may have adverse effects due to disruption of the cascade’s
pleiotropic physiological functions (DiDonato et al., 2012).
Our data in ﬁbroblasts echo this concern and suggest that
complete, irreversible and long-term inhibition of IKKβ may
lead to chronic oxidative stress, and increase the risks for
ﬁbrogenesis and senescence.
MATERIALS AND METHODS
Viruses, plasmids, reagents and antibodies
The adenoviral expression vectors for IKKβ, SMAD7, β-GAL, GFP
and GFP-Cre were from Drs. Yi Zheng at the Cincinnati Children’s
Hospital, Yinling Hu at the National Cancer Institute, and Chia-yang
Liu at Indiana University. The reporter plasmids, NF-κB-luc, SBE-
Luc, AP-1-Luc, and the Tgfβ1, Tgfβ2 and Tgfβ3 promoter-luc were
obtained from Drs. Edward B. Leof at Mayo Clinic and Alvaro Puga
at the University of Cincinnati (Tojima et al., 2000). Expression
vector for SOD2 was from Dr. Shanglin Shi at the University of
Kentucky and Bdm-c-Jun was described before (Geh et al., 2011).
TGFβ1 was from PeproTech, NAC, BSO and DPI were from Sigma-
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Figure 4. ROS accumulation leads to TGFβ activation in IKKβ-null cells. (A) Wild type and Ikkβ−/− cells and (B) wild type and
p65−/− cells were examined for mRNA of oxidative stress marker Hmox-1 and/or redox scavenger gene Sod2. (C) The wild type and
Ikkβ−/− cells with or without Ad-IKKβ infection were examined for p65 binding of the Sod2 enhancer and RNA Pol II occupancy of the
Sod2 promoter. (D) The Ikkβ−/− cells were transfected with luciferase reporters for AP-1, SMAD and Tgfβ2 promoter, together with
either an empty vector or SOD2 expression plasmids. The luciferase activities in SOD2 transfected cells were compared to those in
empty vector transfected cells, designated as 1. (E) The wild type cells were either un-transfected or transfected with Tgfβ2 promoter
reporter, and treated with pro-oxidant BSO. The Tgfβ2mRNA expression and promoter activity were examined. The Ikkβ−/− cells were
either un-transfected or treanfected with the luciferase reporter plasmids for Tgfβ2 promoter or SMAD (SEB-luc). The cells were
treated with anti-oxidant NAC, and were examined for (F) Tgfβ2 mRNA expression and luciferase activity, and (G) migration by the
in vitro wound healing assays. Results represent the mean values ± SD from at least three independent experiments. *P < 0.05,
**P < 0.01 and ***P < 0.001 were considered signiﬁcantly different from the wild type or control samples.
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antibodies were used in the study: anti- IKKα, -IKKβ, -IkBα, and -p-
SMAD2 (Ser-465, 467) from Cell Signaling, anti-pan TGFβ from
R&D Systems, anti-α-SMA from Abcam, anti-β-actin from Sigma-
Aldrich, anti-γH2AX from Novus Biologicals, anti-PolII, -H3, -
H3K27Me3, H3K9Me2, H3K9Ac and H3K4Me3 from EMD Millipore,
and anti-p65, -c-Jun, and IgG from Santa Cruz Biotechnologies.
Mouse ﬁbroblasts, cell culture, transfection, infection and luciferase
assays
The wild type, ﬁbroblasts deﬁcient in IKKβ, IKKα and p65 were gifts
from Drs. Karin and Zandi, and were maintained under culture
conditions as described (Chen et al., 2006). The IkkβF/F, IkkβF/F/
Tgfbr2F/F and c-JunF/F ﬁbroblasts were prepared using E13.5
embryos following standard 3T3 protocol (Aaronson and Todaro,
1968). The cells were cultured in DMEM supplemented with 10%
FBS, 50 U/mL penicillin, 50 mg/mL streptomycin for less than 10
passages before used for experiments or adenoviral infection. Some
of adenoviral infected cells were allowed to grow for 6 months with
approximately 50 passages. Adenoviruses were used at 100–500
PFU to infect 70% conﬂuent cells as described before (Peng et al.,
2010). Cells were transfected using the lipofectamin plus method
and Fireﬂy and Renilla luciferase activities were measured 24 to 48 h
after transfection following the manufacture’s protocols (Thermo
Fisher Scientiﬁc).
Western blotting, ROSmeasurements, SA-β-Gal activity and in vitro
wound healing assays
The SA-β-Gal activities were measured at the PH 6.0 using Beta-Glo
Assay system (Promega), Western blotting, measurement of ROS
and GSH, and the in vitro wound healing assays were done as pre-
viously described (Zhang et al., 2003; Peng et al., 2010). The con-
ditional medium used for in vitro wound healing assays was derived
from fresh medium overlaid on wild type or Ikkβ−/− cells for 24 h.
RNA isolation, reverse transcription and gene expression proﬁling
RNA was extracted, labeled and hybridized to Affymetrix Mouse
Genome 430 2.0 Arrays using standard protocol (Medvedovic et al.,
2009). Data was processed by performing background correction,
quantile normalization, and calculation of expression set summaries
using the Robust Multichip Average (RMA) protocol (Irizarry et al.,
2003) as implemented in the Bioconductor affy package. Differen-
tially expressed genes between two groups were identiﬁed by two-
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Figure 5. Activation of ROS-TGFβ-NOX ampliﬁcation loop in the IKKβ-null cells. The intracellular GSH in wild type, TGFβ1
treated wild type and Ikkβ−/− cells, (A) in the presence or absence of the TGFβ receptor inhibitor SB505124, or (C) in the presence or
absence of the NOX inhibitor DPI. (B) The mRNA of genes coding for components of the NADH complexes in IKKβ-competent, i.e.
wild type and Ikkβ−/−/Ad-IKKβ, and IKKβ-deﬁcient, i.e. Ikkβ−/− and Ikkβ−/−/Ad-β-Gal, cells. (D) The mRNA for oxidative stress marker
Hmox-1 in wild type, Ikkβ−/− and in IkkβF/F ﬁbroblasts infected with Ad-Cre for 0 to 180 days with or without Ad-IKKβ. Results
represent the mean values ± SD from at least three independent experiments. *P < 0.05, **P < 0.01 and ***P < 0.001 were considered
signiﬁcantly different from the wild type or control samples.
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(IBMT) (Sartor et al., 2006). Pathway enrichment analysis was
performed using the LRpath methodology (Sartor et al., 2009)
implemented in the CLEAN package (Freudenberg et al., 2009).
Quantitative RT-PCR (qRT-PCR), chromatin-immunopreciptation
(ChIP) and telomere measurement
qRT-PCR was performed using a DNA Engine Opticon2 Real-Time
PCR Detection System (MJ Research) and SYBR Green qPCR
MasterMix (Applied Biosystems) and primers for the genes of
interest as listed in Table S1. All experiments were performed at
least in triplicates. The relative differences in qRT-PCR among
samples were determined by the ΔCT value as described previously
(Schnekenburger et al., 2007). Hence, the ΔCT value for each
sample was calculated by subtracting cycle threshold (CT) value
(obtained from the means of replicates) of the input DNA (or Gapdh
signal) from that of each sample in order to normalize ChIP assay (or
to normalize gene expression) results. The ΔΔCT value was cal-
culated by subtracting control ΔCT values from the corresponding
experimental ΔCT values. The resulting values were converted to
fold changes over control by raising 2 to the power of −ΔCT values.
ChIP was performed following the protocol described previously
(Schnekenburger et al., 2007). Brieﬂy, cells were ﬁxed for 10 min
with 1% formaldehyde, followed by addition of 0.125 mol/L glycine
for 5 min to stop cross-linking. Cells were washed with ice-cold PBS
and harvested in cell lysis buffer (5 mmol/L PIPES [pH 8.0],
85 mmol/L KCl, 0.5% NP-40, and protease inhibitor cocktail [Roche])
for 10 min on ice. The nuclei were pelleted, resuspended in nucleus
lysis buffer (50 mmol/L Tris-HCl [pH 8.1], 10 mmol/L EDTA, 1% SDS,
and protease inhibitor cocktail), and incubated on ice for 10 min.
Chromatin was sheared to a size range of 0.3 to 0.8 kb by sonica-
tion. After centrifugation to remove cell debris, chromatin was pre-
cleared for 1 h at 4°C with a 50% gel slurry of protein A-agarose
beads saturated with salmon sperm DNA (Upstate), and then diluted
three times in IP dilution buffer (16.7 mmol/L Tris-Cl [pH 8.1],
167 mmol/L NaCl, 1.2 mmol/L EDTA, 1.1% Triton X-100, 0.01%
sodium dodecyl sulfate) with 10% of the supernatants used as input.
The diluted chromatin was incubated with antibodies speciﬁc for the
proteins of interest for 2 h at 4°C, followed by addition of a 50% gel
slurry of protein A-agarose and incubation overnight (Upstate). The
agarose beads were pelleted and washed twice with 1× dialysis
buffer (50 mmol/L Tris-HCl [pH 8.0], 2 mmol/L EDTA, 0.2% Sarkosyl)
and four times with IP wash buffer (100 mmol/L Tris-HCl [pH 9.0],
500 mmol/L LiCl, 1% NP-40, 1% deoxycholic acid). Precipitated
chromatin complexes were removed from the beads by incubation
with elution buffer (50 mmol/L NaHCO3, 1% SDS) with mild vor-



















































































































































Figure 6. c-Jun regulates TGFβ expression in IKKβ-null cells. The wild type cells with or without BSO treatment, and the Ikkβ−/−
cells with or without Ad-IKKβ infection or NAC treatment were examined for (A) luciferase activity following AP-1-luc plasmid
transfection, and (B and C) ChIP assays for (B) c-Jun binding of the Tgfβ2 enhancer and (C) H3K4me3 modiﬁcation of the Tgfβ2
promoters. The Ikkβ−/− cells were transfected with a dominant negative c-Jun (bdm-c-Jun) expression plasmids, and (D) together with
Tgfb2-luc and examined for the luciferase activities, and (E) examined for the Tgfb2mRNA. (F) The mRNA for Tgfb2 and Hmox-1 was
examined in c-JunF/F cells infected with Ad-Cre or Ad-GFP and treated with BSO. Results represent the mean values ± SD from at
least three independent experiments. *P < 0.05, **P < 0.01 and ***P < 0.001 were considered signiﬁcantly different from the un-
treated wild type samples; ###P < 0.001 was signiﬁcantly different from the un-treated Ikkβ−/− samples.
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Cross-linking was reversed by adding NaCl to a ﬁnal concentration
of 0.3 mol/L and incubating overnight at 65°C in the presence of
RNase A. Samples were then digested with proteinase K at 45°C for
1.5 h. DNA was puriﬁed by chromatography on QIAquick columns







































































































Figure 7. Phenotype of the IKKβ-deﬁcient cells. The wild type, Ikkβ−/−, IkkβF/F/Ad-GFP and IkkβF/F/Ad-Cre cells were examined for
(A) SA-β-gal activity, (B) expression of senescent markers, p21 and Fn, (C) expression of IKKβ, β-actin and γH2AX, a marker for DNA
damage, and (D) the telomere length. Results represent the mean values ± SD from at least three independent experiments.
* P < 0.05, ** P < 0.01 and *** P < 0.001 were considered signiﬁcantly different from the wild type or control samples. (E) A proposed
model depicting the role of IKKβ in the regulation of the ROS-TGFβ autocrine ampliﬁcation loop. Speciﬁcally, IKKβ acts through p65 to
regulate expression of anti-oxidant genes, such as SOD2. Loss of IKKβ decreases SOD2 expression and dampens the scavenger
capacity, resulting in ROS accumulation and AP-1/c-Jun activation. The AP-1/c-Jun regulates TGFβ expression thereby activating the
TGFβ-NOX axis to further potentiate ROS accumulation. The ampliﬁcation of the ROS-TGFβ-NOX axis eventually leads to increased
cell migration, myoﬁbroblast transformation and senescence.
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The telomere length was measured using Q-PCR as described
(Callicott and Womack, 2006). Brieﬂy, the genomic DNA were
extracted using a QIAmp DNA micro Kit (Qiagen, Valencia, CA,
USA) and quantiﬁed.
PCR reactions were performed on the ABI Prism 7700 Sequence
Detection System (Applied Biosystems), using telomeric primers for
the reference control gene (mouse 36B4 single copy gene). The
telomere signal was normalized to the signal from the single-copy
gene to generate a relative telomere to single copy gene (T/S) ratio
indicative of relative telomere length. Equal amounts of DNA (300
pg) were used for each reaction with several repeats and average
telomere length was calculated.
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